Evidence map›Paper›PMID 36851254›Full record

ArticleVaccines2023

Identification of an Optimal COVID-19 Booster Allocation Strategy to Minimize Hospital Bed-Days with a Fixed Healthcare Budget.

Ritika Kapoor, Baudouin Standaert, Edmund J Pezalla, Nadia Demarteau, Kelly Sutton, Eszter Tichy, George Bungey, Sofie Arnetorp, Klas Bergenheim, Duncan Darroch-Thompson and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ritika KapoorEvidera, PPD Singapore, 08-11, 1 Fusionopolis Walk, Singapore 138628, Singapore.
Baudouin StandaertFaculty of Medicine and Life Sciences, University of Hasselt, Agoralaan, 3590 Diepenbeek, Belgium.ORCID 0000-0001-6801-9654
Edmund J PezallaEnlightenment Bioconsult, LLC, 140 S Beach Street, Suite 310, Daytona Beach, FL 32114, USA.
Nadia DemarteauEvidera, 1932 Brussels, Belgium.
Kelly SuttonEvidera, Melbourne, VIC 3004, Australia.ORCID 0000-0001-7809-8974
Eszter TichyEvidera, H-1113 Budapest, Hungary.
George BungeyEvidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK.
Sofie ArnetorpHealth Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden.
Klas BergenheimHealth Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, 431 83 Gothenberg, Sweden.
Duncan Darroch-ThompsonInternational Market Access, Vaccines and Immune Therapies, AstraZeneca, Singapore 339510, Singapore.
Wilhelmine MeerausMedical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.
Lucas M OkumuraHealth Economics & Payer Evidence, BioPharmaceuticals R&D, AstraZeneca, São Paulo 06709-000, Brazil.
Renata Tiene de Carvalho YokotaMedical Evidence, Vaccines and Immune Therapies, AstraZeneca, Cambridge CB2 8PA, UK.
Ray GaniEvidera, PPD the Ark, 2nd Floor, 201 Talgarth Road, London W6 8BJ, UK.
Terry NolanThe Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC 3010, Australia.

Funding

AstraZeneca (United Kingdom) NA
6 · The paper itself

Abstract

Healthcare decision-makers face difficult decisions regarding COVID-19 booster selection given limited budgets and the need to maximize healthcare gain. A constrained optimization (CO) model was developed to identify booster allocation strategies that minimize bed-days by varying the proportion of the eligible population receiving different boosters, stratified by age, and given limited healthcare expenditure. Three booster options were included: B

Indexed as

boosterbooster allocationbudget and healthcare resourcesbudget constraintconstrained optimization modelCOVID-19 vaccination

Identifiers

PMID36851254
PMCPMC9965991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.